OAR 836-200-0510
Account Generation Requirement


(1) No later than March 15, 2019, all reporting manufacturers required to file a report by July 1, 2019, under OAR 836-200-0515 (Threshold for Reporting Drug Price Increase) (1) must create an online account with the department.
(2) Beginning in 2020 and for any subsequent year, reporting manufacturers without an online account with the department that are required to file a report by March 15 of that year under OAR 836-200-0515 (Threshold for Reporting Drug Price Increase) (2) must create an online account with the department no later than February 15 of that same year.
(3) Reporting manufacturers without an online account with the department that are required to file a new specialty drug report under OAR 836-200-0520 (Threshold for Reporting New Specialty Drug) must create an online account with the department no later than 10 days prior to submitting the report.

Source: Rule 836-200-0510 — Account Generation Requirement, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=836-200-0510.

836–200–0000
Statutory Authority
836–200–0010
Assessments
836–200–0020
Filing Procedures
836–200–0030
Form 10 K and Other Financial Stability Filings
836–200–0040
Reimbursement Insurance Policy
836–200–0050
Registration Requirements Not Exclusive
836–200–0055
Annual Report
836–200–0060
Service on Registrant
836–200–0100
Notice, Collision Damage Waivers
836–200–0105
Statutory Authority
836–200–0110
Registration Procedures
836–200–0120
Warranty
836–200–0130
Reimbursement Insurance Policy
836–200–0140
Registration Requirements Not Exclusive
836–200–0200
License, Discount Medical Plan Organization
836–200–0210
Renewal of expired license
836–200–0215
One-time processing fee, cancelled application
836–200–0220
License Requirement Not Exclusive
836–200–0250
Purpose and Authority
836–200–0255
Registration of Contracting Entity
836–200–0300
Statement of Purpose
836–200–0305
Retainer Medical Practice Application for Certification
836–200–0310
Retainer Medical Practice Application for Renewal
836–200–0315
Disclosures
836–200–0401
Statement of Purpose
836–200–0406
Application Requirements for Pharmacy Benefit Manager
836–200–0411
Renewal of Pharmacy Benefit Registration
836–200–0416
Registration Requirements Not Exclusive
836–200–0421
Service on Registrant
836–200–0436
Submission of Complaints
836–200–0440
Market Conduct Requirements for Pharmacy Benefit Managers
836–200–0500
Purpose and Statutory Authority
836–200–0505
Definitions
836–200–0510
Account Generation Requirement
836–200–0515
Threshold for Reporting Drug Price Increase
836–200–0520
Threshold for Reporting New Specialty Drug
836–200–0525
Expectations of Reporting Manufacturers
836–200–0530
Form and Manner Requirements for Drug Pricing Reporting
836–200–0535
Additional Information Requests
836–200–0540
Information Claimed to be Trade Secret
836–200–0545
Public Disclosure of Prescription Drug Manufacturer Filings
836–200–0550
Consumer Notices to the Department
836–200–0555
Assessments Against Prescription Drug Manufacturers
836–200–0560
Civil Penalties
Last Updated

Jun. 8, 2021

Rule 836-200-0510’s source at or​.us